Cleared Traditional

K102965 - CELOX TRAUMA GAUZE AG, CELOX HEMOSTATIC ANTIBACTERIAL TRAUMA GAUZE, OMNI-STAT TRAUMA GAUZE AG, OMNI-STAT HEMOSTATIC ANTI (FDA 510(k) Clearance)

Dec 2010
Decision
64d
Days
Risk

K102965 is an FDA 510(k) clearance for the CELOX TRAUMA GAUZE AG, CELOX HEMOSTATIC ANTIBACTERIAL TRAUMA GAUZE, OMNI-STAT TRAUMA GAUZE AG, OMNI-STAT HEMOSTATIC ANTI. This device is classified as a Hemostatic Wound Dressing Without Thrombin Or Other Biologics.

Submitted by Medtrade Products , Ltd. (Cheshire, GB). The FDA issued a Cleared decision on December 8, 2010, 64 days after receiving the submission on October 5, 2010.

This device falls under the General & Plastic Surgery FDA review panel. To Temporarily Control Bleeding And Cover External Wounds..

Submission Details

510(k) Number K102965 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 2010
Decision Date December 08, 2010
Days to Decision 64 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QSY — Hemostatic Wound Dressing Without Thrombin Or Other Biologics
Device Class
Definition To Temporarily Control Bleeding And Cover External Wounds.